Valuation : Stereotaxis, Inc.

Market Cap 139M 120M 113M 103M 193M 13.16B 193M 1.33B 516M 6.74B 523M 512M 21.76B P/E 2026 *
-6.84x
P/E 2027 * -9.48x
Enterprise Value 139M 120M 113M 103M 193M 13.16B 193M 1.33B 516M 6.74B 523M 512M 21.76B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 3.05x
Free-Float
78.85%
Yield 2026 *
-
Yield 2027 * -
1 week-4.14%
Current month-3.47%
3 months-21.91%
6 months-36.53%
Current year-39.57%
1 week 1.35
Extreme 1.35
1.49
1 month 1.3
Extreme 1.3
1.51
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/26 A Free

Director

43,103 0.0441%
7/1/26 A Free

Director

43,103 0.0441%
7/1/26 A
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.14%-52.07%-24.46% 139M
-0.75%-1.35%+24.60%+13.24% 227B
-1.60%-3.89%+3.72%-20.39% 146B
-0.85%-1.58%-21.45%+19.18% 130B
+1.81%+2.05%-55.42%-10.32% 69.27B
+0.13%-0.34%+11.07%+18.34% 51.82B
+0.49%-1.32%-17.27%-14.42% 50.45B
+0.59%-1.94%+17.17%+27.06% 42.53B
-1.01%-1.28%+33.64%+48.14% 40.22B
-1.55%+1.22%+120.58%+36.88% 32.95B
Average -0.27%-1.82%+6.46%+9.33% 78.99B
Weighted average by Cap. -0.54%-1.55%+6.66%+8.00%

Financials

2026 *2027 *
Net sales 34.33M 29.57M 27.78M 25.39M 47.51M 3.24B 47.67M 328M 127M 1.66B 129M 126M 5.36B 45.67M 39.33M 36.94M 33.77M 63.19M 4.32B 63.41M 437M 169M 2.21B 171M 168M 7.13B
Net income -20.13M -17.34M -16.29M -14.89M -27.86M -1.9B -27.96M -193M -74.65M -975M -75.6M -73.95M -3.15B -14.77M -12.72M -11.95M -10.92M -20.43M -1.4B -20.5M -141M -54.75M -715M -55.45M -54.24M -2.31B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
04/09/26 $1.390 0.00% 344,434
03/09/26 $1.390 +0.72% 399,628
02/09/26 $1.380 +0.73% 315,740
01/09/26 $1.370 -4.86% 598,718
31/08/26 $1.440 -0.69% 593,115
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.390USD
Average target price
3.000USD
Spread / Average Target
+115.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock